ETR:RHK

RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) Stock Forecast, Price & News

€16.46

0.00 (0.00 %)

(As of 10/23/2020 12:00 AM ET)

Add

Compare

Today's Range

€16.46

Now: €16.46▼

€16.52

50-Day Range

€15.82

MA: €16.25▼

€16.64

52-Week Range

€14.14

Now: €16.46▼

€19.70

Volume1,365 shs

Average Volume43,281 shs

Market Capitalization$1.10 billion

P/E Ratio57.35

Dividend Yield1.60%

BetaN/A

RHÃ-N-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. As of December 31, 2019, it operated 8 hospitals and 5,312 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.

Beat the Market (BTM) Rank^™

0.8 Analyst's Opinion

Consensus Rating
RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) has received a consensus rating of Hold. The company's average rating score is 1.50, and is based on no buy ratings, 2 hold ratings, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of €17.63, RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) has a forecasted upside of 7.1% from its current price of €16.46.
Amount of Analyst Coverage
RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) has received no research coverage in the past 90 days.

2.0 Community Rank

Outperform Votes
RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) has received 138 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) has received 204 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) has received 59.65% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) and other stocks. Vote “Outperform” if you believe RHK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RHK will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.8 Dividend Strength

Dividend Yield
RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) pays a meaningful dividend of 1.60%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) is 101.05%. Payout ratios above 75% are not desirable because they may not be sustainable.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) is 57.35, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 19.86.
Price to Earnings Ratio vs. Sector
The P/E ratio of RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) is 57.35, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.47.
Price to Earnings Growth Ratio
RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) has a PEG Ratio of 4.90. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) has a P/B Ratio of 0.95. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.84 out of 5 stars

Industry, Sector and Symbol

Stock Exchange ETR

Industry Medical Care

Sub-IndustryN/A

SectorMedical

Current SymbolETR:RHK

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.rhoen-klinikum-ag.com

Phone+49-9-771650

Employees18,131

Debt

Debt-to-Equity Ratio14.59

Current Ratio1.36

Quick Ratio1.24

Price-To-Earnings

Trailing P/E Ratio57.35

Forward P/E Ratio20.84

P/E Growth4.9

Sales & Book Value

Annual Sales$1.52 billion

Price / Sales0.73

Cash Flow€5.30 per share

Price / Cash Flow3.11

Book Value€17.33 per share

Price / Book0.95

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares66,938,500

Market Cap$1.10 billion

Next Earnings Date11/6/2020 (Estimated)

OptionableNot Optionable

€16.46

0.00 (0.00 %)

(As of 10/23/2020 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive RHK News and Ratings via Email

Sign-up to receive the latest news and ratings for RHK and its competitors with MarketBeat's FREE daily newsletter.

RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) (ETR:RHK) Frequently Asked Questions

How has RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)'s stock price been impacted by Coronavirus?

RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)'s stock was trading at €18.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RHK stock has decreased by 8.8% and is now trading at €16.46.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) in the last year. There are currently 2 sell ratings and 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for RHÖN-KLINIKUM Aktiengesellschaft (RHK.F).

When is RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)'s next earnings date?

RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for RHÖN-KLINIKUM Aktiengesellschaft (RHK.F).

What price target have analysts set for RHK?

4 analysts have issued 1 year target prices for RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)'s shares. Their forecasts range from €16.50 to €18.00. On average, they expect RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)'s share price to reach €17.63 in the next twelve months. This suggests a possible upside of 7.1% from the stock's current price.
View analysts' price targets for RHÖN-KLINIKUM Aktiengesellschaft (RHK.F).

Who are some of RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)'s key competitors?

Some companies that are related to RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) include Mediclinic International (MDC), CareTech Holdings PLC (CTH.L) (CTH), Spire Healthcare Group plc (SPI.L) (SPI), Sanara MedTech (SMTI), Georgia Healthcare Group (GHG), CENTRIC HEALTH (CHH), Assure Holdings Corp. (IOM.V) (IOM), Totally plc (TLY.L) (TLY), Nobilis Health (HLTH), Venn Life Sciences (VENN), Widecells Group (WDC), Agility Health (AHI), (PHGI) (PHGI), Amadeus It Group (AMS) and Blvd Centers (CXV).
View all competitors.

What other stocks do shareholders of RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) investors own include Seabridge Gold (SA), iShares Silver Trust (SLV), The Walt Disney (DIS), Alamos Gold (AGI), Anova Metals (AWV), Bayerische Motoren Werke Aktiengesellschaft (BMW.F) (BMW), Anheuser Busch Inbev (BUD), Cognex (CGNX), Canadian National Railway (CNI) and Discovery (DISCK).

Who are RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)'s key executives?

RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)'s management team includes the following people:

Prof. Bernd Griewing, Member of Board of Management
Dr. Gunther Karl WeiÃ, Member of Management Board (Age 54, Pay $1.03M)
Mr. Eugen MÃ¼nch, Chief Representative
Dr. Christian Hoftberger, Member of Management Board
Dr. Stefan Stranz, Member of Management Board

What is RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)'s stock symbol?

RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) trades on the ETR under the ticker symbol "RHK."

What is RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)'s stock price today?

One share of RHK stock can currently be purchased for approximately €16.46.

How big of a company is RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)?

RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) has a market capitalization of $1.10 billion and generates $1.52 billion in revenue each year. RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) employs 18,131 workers across the globe.

What is RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)'s official website?

The official website for RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) is www.rhoen-klinikum-ag.com.

How can I contact RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)?

RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)'s mailing address is Schlossplatz 1, BAD NEUSTADT AN DER SAALE, 97616, Germany. The company can be reached via phone at +49-9-771650.

This page was last updated on 10/24/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings